Silvia Murillo-Cuesta
Silvia Murillo-Cuesta
1Institute of Biomedical Research “Alberto Sols” (IIBM), Spanish National Research Council–Autonomous University of Madrid (CSIC-UAM), Madrid, Spain
2Centre for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos III (ISCIII), Madrid, Spain
3Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain
1,2,3,*,
Lourdes Rodríguez-de la Rosa
Lourdes Rodríguez-de la Rosa
1Institute of Biomedical Research “Alberto Sols” (IIBM), Spanish National Research Council–Autonomous University of Madrid (CSIC-UAM), Madrid, Spain
2Centre for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos III (ISCIII), Madrid, Spain
3Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain
1,2,3,
Julio Contreras
Julio Contreras
1Institute of Biomedical Research “Alberto Sols” (IIBM), Spanish National Research Council–Autonomous University of Madrid (CSIC-UAM), Madrid, Spain
2Centre for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos III (ISCIII), Madrid, Spain
4Veterinary Faculty, Complutense University of Madrid, Madrid, Spain
1,2,4,
Adelaida M Celaya
Adelaida M Celaya
1Institute of Biomedical Research “Alberto Sols” (IIBM), Spanish National Research Council–Autonomous University of Madrid (CSIC-UAM), Madrid, Spain
2Centre for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos III (ISCIII), Madrid, Spain
1,2,
Guadalupe Camarero
Guadalupe Camarero
1Institute of Biomedical Research “Alberto Sols” (IIBM), Spanish National Research Council–Autonomous University of Madrid (CSIC-UAM), Madrid, Spain
2Centre for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos III (ISCIII), Madrid, Spain
3Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain
1,2,3,
Teresa Rivera
Teresa Rivera
1Institute of Biomedical Research “Alberto Sols” (IIBM), Spanish National Research Council–Autonomous University of Madrid (CSIC-UAM), Madrid, Spain
2Centre for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos III (ISCIII), Madrid, Spain
5Príncipe de Asturias University Hospital, University of Alcalá, Alcalá de Henares, Madrid, Spain
1,2,5,†,
Isabel Varela-Nieto
Isabel Varela-Nieto
1Institute of Biomedical Research “Alberto Sols” (IIBM), Spanish National Research Council–Autonomous University of Madrid (CSIC-UAM), Madrid, Spain
2Centre for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos III (ISCIII), Madrid, Spain
3Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain
1,2,3,†
1Institute of Biomedical Research “Alberto Sols” (IIBM), Spanish National Research Council–Autonomous University of Madrid (CSIC-UAM), Madrid, Spain
2Centre for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos III (ISCIII), Madrid, Spain
3Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain
4Veterinary Faculty, Complutense University of Madrid, Madrid, Spain
5Príncipe de Asturias University Hospital, University of Alcalá, Alcalá de Henares, Madrid, Spain
Edited and reviewed by: Paula I. Moreira, University of Coimbra, Portugal
✉*Correspondence: Silvia Murillo-Cuesta, smurillo@iib.uam.es
† These authors have contributed equally to this work.
Received 2015 Apr 17; Accepted 2015 Apr 22; Collection date 2015.
Keywords: cochlear injury, inflammation, noise-induced hearing loss, protection, TGF-ß
Copyright © 2015 Murillo-Cuesta, Rodríguez-de la Rosa, Contreras, Celaya, Camarero, Rivera and Varela-Nieto.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
